Select a company

Go

Company Stage

  • Private (seed)
  • Private (post-seed)
  • Quoted

Sector

  • Biotech
  • Healthcare
  • Cleantech
  • Technology
  • Other

University

  • University of Bath
  • University of Bristol
  • University of Cardiff
  • University of Glasgow
  • University of Leeds
  • King's College London
  • Queen Mary, University of London
  • University of Manchester
  • University of Nottingham
  • University of Oxford
  • University of Sheffield
  • University of Southampton
  • University of Surrey
  • Swansea University
  • University of York
  • Other

Stakeholder

  • IP Group
  • IP Venture Fund
  • IP Venture Fund II
  • Top 10 Holdings
    by value
Medical Equipment & Supplies

University: Southampton

Company Stage: Private (post-seed)

Website: http://www.stratophase.com

Stratophase

Stratophase supplies optoelectronic components and specialises in periodically poled lithium niobate (PPLN) for wavelength conversion and the direct writing of gratings and waveguides on planar surfaces.

Wavelength conversion enables the wavelength of existing low cost lasers to be converted to wavelengths that are currently difficult to generate or are generated by much more expensive lasers. This is particularly important in the drive to reduce costs and open new applications in, for example, the sensors and telecoms markets.

As at 31 Dec 2013

IP Group holding

 

1.3%

Holding represents undiluted beneficial equity interest excluding debt

Related news

There is currently no news available.

More portfolio news